SAN DIEGO -- Results from a small single-center study showed that treatment with a gene therapy involving the use of lentiviral vector-transduced autologous hematopoietic stem cells (HSCs) increased ...
Lentiviral vectors have emerged as indispensable tools in gene therapy, offering the ability to integrate therapeutic genes into both dividing and non-dividing cells. Their unique capacity to achieve ...
The β 2 common integrin subunit CD18 is essential for leukocyte–endothelial adhesion and extravasation to inflamed or infected tissue. Damaging variants in ITGB2 ...
Vector suppliers need better ways of growing adherent cells, according to the team behind a new single-use culturing platform, who say current technologies are not suited to industrial-scale ...
VENLO, the Netherlands--(BUSINESS WIRE)-- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its cell and gene therapy (CGT) portfolio with an enhanced digital PCR ...
Cell and gene therapies offer hope for previously untreatable diseases, with viral vectors currently favored as the primary gene delivery method. To meet patient needs, reliable and cost-effective ...
VintaBio announced it has filed provisional patents with the U.S. Patent and Trademark Office for a new approach to manufacturing biotherapeutics using adherent culturing methods in small-scale ...
Therapeutics Co. Ltd. ( ($HK:2126) ) has issued an announcement. JW Therapeutics announced that the National Medical Products ...
HOPEWELL, N.J., June 27, 2025 /PRNewswire/ -- ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced the opening of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback